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ABSTRACT
Objectives: To explore the opinions, the usage and the patient education given on nasal saline
irrigation by physicians and pharmaceutical personnel working in Finland.
Design: An internet-based survey with predetermined, multiple-choice answers.
Setting: Primary care centres, occupational health centres and private care centres in Eastern
Finland as well as pharmacies in Finland.
Main outcome measures: Healthcare professionals views, practice and general knowledge of
nasal irrigation for sinonasal symptoms and conditions.
Results: We received 595 completed surveys (110 physicians, 485 pharmacists). The majority of
the respondents recommended nasal saline irrigation for their patients either as a symptomatic
treatment (98.0%) or to treat a specific condition (97.5%) such as acute rhinosinusitis, chronic
rhinosinusitis and allergic rhinitis. Nasal saline irrigation was also often recommended as a
prophylaxis for airway-infections (71.9%) and to enhance the health of the nasal mucosa
(58.2%). In general, the possible adverse effects were recognised poorly by both professions.
There was a clear difference between the two professions, as physicians were more conservative
in recommending nasal saline irrigation and recognised possible adverse effects, such as epi-
staxis, pain, and dryness of the nose, better (75% vs. 59%, p¼ 0.002).
Conclusions: Nasal saline irrigation seems to be a popular treatment recommended by many
health care professionals in Finland. Physicians and pharmaceutical personnel had variable opin-
ions on the indications, utility and risks of nasal saline irrigation. There are also clear differences
between physicians and pharmaceutical personnel’s practices. There is a need to better educate
professionals about nasal saline irrigation and to further study whether nasal saline irrigation is
efficient and safe option for the different common sinonasal conditions.
KEY POINTS
 Little information is available on how physicians and pharmacists recommend nasal saline irri-
gation as a symptomatic treatment.
 Physicians and pharmacists seem to have variable opinions about the indications, utility and
safety of nasal saline irrigation.
 The patient education given is in general very heterogenous.
 Both professions require more education to ensure that the usage remains as safe as possible
for the patient.
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The prevalence of acute rhinosinusitis (ARS) is about
6–15% in the Western world, chronic rhinosinusitis
(CRS) is 10% and allergic rhinitis (AR) is about 25%
[1–3]. The burden of sinonasal diseases is a global
health and financial challenge. For example, in the US
the annual direct costs for CRS are 8.6 billion dollars
and rhinosinusitis is one of the top-ten most costly
health conditions when both direct and indirect costs
are taken into account [1]. Hence, cost-effective treat-
ments are in high demand.
Many over-the-counter treatments claim to alleviate
nasal symptoms, but their efficacy remains largely
unproven [4]. In nasal saline irrigation (NSI) the patient
rinses nasal cavities by instilling either isotonic or
hypertonic saline solution into one nostril and allows
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it to drain out from the other nostril [5–8]. Some
believe it is an efficient, cheap and safe alternative
treatment [9]. However, the grade of evidence for its
effectiveness is of low quality based on Cochrane
reviews and the reviews conclude that no recommen-
dations can be made [6–8] (Table 1). Still, it is often
recommended in different guidelines (Table 2). It is
also still unclear whether isotonic or hypertonic solu-
tions should be favoured [6–8]. NSI is also used in
postoperative care to promote mucosal recovery
[18,19]. The evidence is limited and no official guide-
lines exist [18,19].
Only a few studies have been made to evaluate the
use of NSI by healthcare professionals [9,20], but
based on those it seems to be quite popular. There is
little evidence of how patients should be educated on
its safe usage and by who [1,3,6–8,11]. This can lead
to undesired and even potentially harmful treatments
such as using hypotonic solutions for irrigation, even
though they have been shown to cause damage to
the respiratory epithelium [21].
We aimed to explore the opinions, the usage and
the patient education given on NSI by physicians and
pharmaceutical personnel working in Finland. Our two
main hypotheses were that there would be significant
differences between the two professions included in




We conducted a cross-sectional survey regarding the
usage of NSI (not including nasal salt sprays) by phar-
macists and physicians in Finland. The survey was car-
ried out between 7 February 2019 and 18 March 2019
using an internet-based survey platform, Surveypal.
The survey was distributed nationwide for pharma-
ceutical personnel, but more locally for the physicians
as we had no means to achieve nationwide coverage.
The anonymous survey was open for six weeks. No
ethical approvals were required for this study.
Setting and population
Pharmaceutical personnel were approached with an
email containing the link to the survey as well as a
short cover letter. The link was included in a regular
newsletter sent to all members of the Association of
Finnish Pharmacies and published on their official
website to eliminate the possibility of selection bias.
Physicians were recruited from a few of the largest
private care centres, primary care centres as well as
occupational health centres in Eastern Finland. Our
target group consisted of primary care physicians,
occupational health physicians and private care physi-
cians, including general practitioners and specialists. If
the invite was accepted, it was generally distributed to
all the working staff by internal email containing the
cover letter.
Questionnaire design
There is no validated survey available, so we had to
develop our own. We settled for 19 multiple-choice
questions. The questionnaire (Appendix 1) was
reviewed and commented by a small group of physi-
cians and pharmacist before finalizing it and translat-
ing it to an internet-based survey system.
Statistical analysis
After closing the survey, we used the automatic tool
from Surveypal to export the data. Every responder
was automatically given a unique, anonymous ID-num-
ber. The authors explored the findings in relation to
the goals of the study and identified those worth of
pursuing more closely. These findings were then
selected for statistical analysis, which was carried out
with the SPSS Base 25.0 Statistical Software Package
(SPSS Inc, Chicago, IL, USA). Descriptive statistics and
proportions for categorical variables were calculated.
Fisher’s exact test was used to determine whether
there was a difference in administering NSI between
physicians and pharmacists as well as other subgroups
and categories. The continuous variables were
Table 1. Recommendations from Cochrane Reviews considering the usage of nasal saline irrigation for different sinonasal dis-
eases and the quality of evidence.
Indication Recommendation Quality of evidence
Acute rhinosinusitis and common cold [6] May be beneficial, no recommendation can be made Low or very low
Allergic rhinitis [8] May be beneficial, no recommendation can be made Low or very low
Chronic sinusitis [7] May be beneficial, no recommendation can be made Low or very low
Atrophic rhinitis [10] No recommendation can be made
Asthma None exist
Post-operative care after functional endoscopic sinus surgery None exist
Regular cleaning after functional endoscopic sinus surgery None exist
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described as median values and interquartile ranges
(IQR). Differences between the two groups for continu-
ous variables were calculated with independent sam-
ples Mann-Whitney U test. Two-tailed p-values of
<0.05 were considered statistically significant.
Results
We received 595 completed surveys, most of which
(485; 81.5%) were from pharmacy personnel. The
remaining 110 (18.5%) answers came from physicians.
A total of 855 people opened the link leading to the
survey (a response rate of 69.6%). We managed to get
answers from 5.6% (485/8862) of all the pharmacy per-
sonnel working in Finland [22]. Because of the method
for distributing the survey, we have no data about how
many physicians we managed to contact and were
unable to estimate the response rate to the survey.
Reported physician subspecialties were general practice
33.6% (37/110), occupational health 47.3% (52/110) and
private care 17.3% (19/110). Most respondents had over
10 years of work experience (384; 64.9%). Our sample
was well represented from a geographical standpoint
and in terms of the working environment of the
respondents (58.7% in cities, 41.3% in population
centres). There were no significant differences when
comparing the answers in terms of working experience
(less than 5 years of experience vs. more than 5 years
of experience). Due to the small sample size of
physician’s subspecialties, it was not feasible to exam-
ine possible differences between them.
Indications for NSI
Most of the respondents recommended NSI for ARS,
CRS, AR and the common cold (Figure 1). NSI was also
administered for asthma and atrophic rhinitis and as
post-operative care for functional endoscopic sinus
surgery. Only a small minority did not recommend NSI
for any of these conditions. Pharmacist recommended
NSI significantly more for different conditions such as
AR, asthma and the common cold (Figure 1).
The sinonasal symptoms for which NSI was most
commonly administered were nasal congestion, facial
pressure and purulent nasal discharge (Figure 2).
Irrigations were a slightly less popular choice for dry-
ness of the nose, runny nose and nasal irritation. Only
a small minority of the respondents did not recom-
mend NSI for any of the previous symptoms.
Pharmacist recommended NSI significantly more for
different symptoms such as itching of the nose, dry-
ness of the nose, nasal congestion, and runny nose.
NSI was also often recommended for the preven-
tion of upper respiratory infections (n¼ 428; 71.9%)
and to enhance the well-being of the nasal mucosa
(n¼ 346; 58.2%). Pharmacist recommended NSI more
frequently for the prevention of infections (77.9% vs.
Table 2. Recommendations from International Guidelines and Finnish National Guidelines considering the usage of nasal saline
irrigation (NSI) for different sinonasal diseases and the strength of recommendation (if reported).
Indication Recommendation Strength of recommendation
Acute rhinosinusitis and common cold (ARS)
EPOS 2020 for adults and children [1] NSI possibly has benefits for symptom
relief mainly in children
Ib#
EPOS 2020 for adults with acute post-viral rhinosinusitis [1] No recommendation can be given based
on very low quality of evidence
EPOS 2020 for adults with acute bacterial rhinosinusitis [1] No recommendation can be given based
on very low quality of evidence
Finnish Guideline: ARS and common cold [11] No mention of NSI
Allergic rhinitis (AR)
ARIA 2008 [3] Recommended in a pharmacy setting
Finnish guideline: AR [12] No mention of NSI
AAFP Clinical Practice Guideline: AR 2015 [13] No mention of NSI
Asthma
Global initiative for asthma (GINA) [14] No mention of NSI
Finnish guideline: Asthma [15] No mention of NSI
International ERS/ATS guideline for asthma [16] No mention of NSI
Atrophic rhinitis
Finnish guideline: Atrophic rhinitis [17] Recommended
Chronic sinusitis (CRS)
EPOS 2020 for adults with chronic rhinosinusitis [1] Recommended Ia
EPOS 2020 for children with chronic rhinosinusitis [1] Recommended Ibþ#
Finnish guideline: CRS [11] Recommended Low
Post-operative care after functional endoscopic sinus surgery (FESS)
No official guidelines exist
Regular cleaning after FESS
No official guidelines exist
Note. EPOS 2020 reports the level of evidence instead of strength of recommendation.Based on older Cochrane reviews, Ia: based on systematic review of RCTs; #Ib: based on individual RCT.
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45.5%, p< 0.001) and for the well-being of the nasal
mucosa (64.1% vs. 31.8%, p< 0.001).
Safety and popularity
The most commonly recognised adverse effects can
be seen in Figure 3. In general, pharmacists recog-
nised fewer possible adverse effects.
53.7% (n¼ 320) of the respondents estimated rec-
ommending irrigations for 1–20% of their patients
with any nasal symptoms and 43.7% (n¼ 260) for
21–100% of the patients, while only 2.5% (n¼ 15) did
not recommend irrigations at all.
Means of irrigation and patient education
In summary, the most popular method for NSI was a
Neti pot (n¼ 477; 80.7%) filled with an isotonic
solution (n¼ 440; 73.9%) that was 30–40 degrees
Celsius (n¼ 417; 70.1%). Hypertonic (n¼ 18; 3.0%) or
hypotonic (n¼ 11; 1.8%) solutions were rarely adminis-
tered and the rest did not instruct the tonicity
(n¼ 126; 21.2%). Volumes of 51–100ml (n¼ 72; 12.2%)
and 101–200ml (n¼ 83; 14.0%) were recommended
the most, while the majority gave no recommendation
at all (n¼ 316; 53.4%). Many of the respondents rec-
ommended homemade solutions (n¼ 483; 81.2%) as
opposed to purchasing ready-to-use nasal solutions
from pharmacies (n¼ 325; 54.6%). Irrigations were
most instructed as a daily (n¼ 222; 37.8%) or twice-a-
day (n¼ 277; 47.2%) therapy. Regular irrigations were
recommended by 77 (12.9%) of the respondents, while
the rest (n¼ 518; 87.1%) opted for a short-term usage
(mean: 6.52 days, SD ¼ 3.9, min ¼ 1 day and max ¼
30 days). There was no significant difference in the
Figure 2. Symptoms that nasal saline irrigation is recommended for by Finnish physicians (n¼ 110) and pharmacists (n¼ 485).
Figure 1. Conditions that nasal saline irrigation is recommended for by Finnish physicians (n¼ 110) and pharmacists (n¼ 485).
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length of the recommended use between pharmacists
and physicians.
Cleaning of the device used for irrigations was
commonly instructed to be done once before or after
use (n¼ 356; 59.8%). Cleaning before and after use
was recommended by 13.9% (n¼ 83) of the respond-
ents, while 21.5% (n¼ 128) recommended cleaning
once a week and 4.7% (n¼ 28) even less frequently.
The most popular cleaning methods were rinsing with
running water (n¼ 272; 45.7%) or cleaning with boil-
ing water (n¼ 214; 36.0%). Physicians were much
more likely to not give instructions regarding the
desired volume (51.3% vs. 60.9%, p¼ 0.073), tonicity
(17.3% vs. 38.1%, p< 0.001), temperature (5.4% vs.
22.7%, p< 0.001) and cleaning (18.6% vs. 51.8%,
p< 0.001) compared to pharmacists.
Discussion
This study was to evaluate how physicians and
pharmaceutical personnel recommend NSI to patients
in Finland. Nasal saline irrigation was recommended
by almost all of the respondents either as a symptom-
atic treatment or for a specific condition. Possible
adverse effects were recognised poorly. Our findings
seem to be in line with the two other studies explor-
ing the usage of NSI by physicians, as they found out
that 99.3% (854/860) or 87% (286/330) of physicians
use NSI either as a standalone or adjunctive therapy
[9,20]. The study by Marchisio et al surveyed the use
of NSI by primary health care pediatricians working in
Northern Italy, while the study by Rabago et al investi-
gated the use by family physicians in Wisconsin, USA.
Both studies focused on the usage of NSI for upper
respiratory infections [9,20].
To our knowledge, this is the first study to show a
clear difference between the two professions in rec-
ommending NSI usage for patients: physicians were
more conservative in recommending NSI and recog-
nised possible adverse effects better. This difference
could be due to physicians knowing the patient’s gen-
eral diseases better, putative risks, or physicians’ lack
of knowledge related to the use of NSI.
In this study, almost all the respondents recom-
mended NSI as a symptomatic treatment for their
patients. It was most frequently administered for nasal
congestion, facial pressure and purulent nasal dis-
charge. In general, pharmacy personnel seemed to
recommend NSI significantly more frequently for
symptomatic treatment than physicians did. Pharmacy
personnel also recommended NSI more readily. This
difference could result from the fact that many of
these symptoms and disorders are mild and thus peo-
ple are more likely to turn to pharmacies for over-the-
counter treatment for their symptoms, rather than to
visit a doctor. Another explanation could be that
physicians have less pressure to offer an instant solu-
tion to a patient’s problem and can more easily adopt
a wait-and-see approach and on the other hand, they
also have alternative management options, including
those not available over-the-counter. It is also possible
that marketing could play some role.
NSI has a low or very low level of evidence in the
treatment of ARS, CRS, AR and the common cold
[6–8]. Interestingly, our study showed that NSI was
also frequently recommended for the prevention of
upper airway infections and the well-being of the
nasal mucosa. Almost a fifth of the responders also
recommended NSI for asthma, even though it is not
included in any of the guidelines [14]. We could not
Figure 3. Possible adverse effects of nasal saline irrigation as reported by physicians (n¼ 110) and pharmacists (n¼ 485) working
in Finland.
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find any studies that have investigated these indica-
tions. Physicians were significantly less likely to recom-
mend irrigations for these reasons. It remains unclear
whether these might be a sole reason for recommend-
ing NSI to an asymptomatic patient or just a con-
ceived beneficial effect on top of the intended
symptomatic treatment.
There is very little information available about the
frequency and the scope of the possible adverse
effects in the literature. Most of the studies included
in the Cochrane reviews had inadequate reporting or
collecting of the possible adverse effects [6–8].
However, dryness of the nose, pain, irritation and epi-
staxis were mentioned [6–8]. Similarly, a significant
portion of our responders thought that NSI carries no
negative side-effects. However, the safety of pro-
longed and regular, multiple times a day usage
is unclear.
At the same time, increasing antimicrobial resist-
ance is an ever-present global threat [23]. A recent
quality assessment study in Denmark showed that
almost 65% of the patients diagnosed with ARS
received antimicrobial treatment in a general practice
setting [24]. The evidence-based acceptable range is
between five to ten per cent – indicating a significant
overuse of antibiotics [25]. This phenomenon is well
recorded in other studies as well [26–29]. A vast
majority of the patients with ARS believe that healing
requires medication and one of the reasons for the
overprescribing is the pressure clinicians feel to meet
the expectations of their patients [30,31]. We believe
this could be one of the reasons behind the observed
popularity of NSI in our study, even though it is not
an evidence-based treatment.
Despite the reported adverse events of NSI, we
found that NSI is recommended to a relatively wide
range of upper airway symptoms, at least in Finland.
Moreover, we found that healthcare and/or pharma-
ceutical professionals give relatively little and very
variable instructions on how to use and take care of
the NSI device. We identified significant differences
between the two professions that can probably be
explained by the different education basis, as physi-
cians’ practices are generally much more in line with
the current guidelines when compared to the pharma-
ceutical personnel. Hence, it might be important to
better deal practical summary of evidence-based con-
sensus of NSI’s indications, its potential risks, and its
use, to all healthcare and pharmaceutical professionals
who work with people having upper airway problems.
There is also a need to study the efficacy and safety
of NSI further in different upper airway conditions.
There has not been a single study of how the patients
use NSI in real life. Patients deserve good education
by professionals as upper airway symptoms are com-
mon and patients seek for symptom relief by using
over-the-counter management. Moreover, not all
patients can follow the written instructions provided
by the device. An option could thus be to provide
publicly available instructions of how to use NSI by
healthcare professionals, such as this instructional
video available at the official website produced jointly
by the Finnish University Hospitals [32]. It is unclear
how many of the professionals know that a video like
this exists and how many recommend it to
their patients.
Our study has some limitations. Selection bias may
have occurred as the survey was distributed for phar-
macists with national-level coverage while physician
recruitment was restricted to the Eastern Finland
region. Secondly, the study design prevented us from
calculating the exact responder rate or performing a
non-responder analysis. It could be thus possible that
those professionals who responded had more positive
opinions towards NSI than the non-responders.
Thirdly, there is a clear bias towards pharmacists as a
clear majority of the responders were pharmacists.
This survey was to evaluate the opinions in general
and thus we were not able to get data of the fre-
quency and methods of how professionals educate
patients to use NSI in their everyday practice. It is also
possible that our findings do not represent the actual
practise or opinions. We acknowledge that the
responding physicians represent only a small portion
(3.7%) of the licenced physicians in Eastern Finland
[33] and thus our results may not fully correspond to
the general opinions of all physicians. However, we
believe our study design was relevant when consider-
ing the goal of our study and that we managed to
reach those goals.
In conclusion, NSI is often recommended to
patients by healthcare or pharmaceutical professionals
in Finland. We demonstrated that pharmaceutical pro-
fessionals recognize less the potential harm of using
NSI and they recommend NSI for a wider range of
sinonasal conditions, including those that have not
currently been included into the evidence-based rec-
ommendations in the guidelines. Also, there is hetero-
geneity in giving instructions on how to perform NSI
and how to take care of the device. There is a need to
improve subjects’ as well as healthcare/pharmaceutical
professionals’ knowledge of NSI. This could be
achieved by open access instructions and videos, but
most importantly, they need to be promoted more
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vigorously to bring them to the attention of the pro-
fessionals. There is also a need to study more the effi-
cacy of NSI in various sinonasal conditions. As of now,
the methods used are very diverse, sometimes even
potentially harmful (i.e. using hypotonic solutions) and
for some questionable indications.
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Translated survey for Finnish physicians and pharmacists
concerning the usage, patient education and knowledge of
nasal saline irrigations (NSI). Questions 2a and 2b were only
asked if the responder was not a physician. Question 10a
was asked only if the responder opted for short-term usage
of NSI instead of regular use. This survey was conducted
with Surveypal. We aimed for a balance between getting
enough information and making the survey as short as pos-
sible to ensure better response rate. To make the data more
easily manageable, we opted mainly for pre-determined
answers in the form of multiple-choice-questions.






f. Over 20 years




d. Other pharmacy personnel
e. Primary care physician
f. Occupational physician
g. Private practioner




















2b. Is your pharmacy located in a city or in a population
centre? (select one)
a. In a city
b. In a population centre
3. Would you recommend nasal saline irrigations (NSI) for






f. All of the above




5. Would you recommend NSI for prophylaxis of upper air-
way infections? (select one)
a. Yes
b. No
6. Would you recommend NSI for the betterment of the
well-being of the nasal mucosa? (select one)
a. Yes
b. No
7. For which of the following symptoms would you recom-
mend NSI for? (you can choose multiple)
a. Itching of the nose
b. Dryness of the nose




g. None of the above
8. For which of the following conditions would you recom-
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f. Regular cleaning of the sinuses after sinus surgery
g. Common cold
h. Post-operative treatment after sinus surgery
i. None of the above
9. Estimate how often do you recommend NSI for a patient







10. Would you recommend NSI to be used regularly or more
as a short-term solution? (select one)
a. Short-term
b. Regularly
10a. The recommended length of use on average?
(open field)
11. How often would you recommend NSI to be adminis-
tered? (select one)
a. Once a week
b. Every few days
c. Once a day
d. Twice a day
e. More than twice a day
12. What mean for NSI would you primarily recommend?
(select one)
a. Neti pot
b. Physiomer Normal Jet & Spray or Strong Jet
c. Syringe








g. I don’t give instructions concerning the volume
14. What should the tonicity of the solution used be?
(select one)
a. Hypotonic (<0.9% NaCl)
b. Isotonic (0.9% NaCl)
c. Hypertonic (>0.9% NaCl)
d. I don’t give instructions concerning the tonicity





d. I don’t give instructions concerning the
temperature
16. What kind of solutions would you recommend for NSI?
(you can choose multiple)
a. Sachet bought from pharmacy or elsewhere
b. Ready-to-use saline from pharmacy or elsewhere
c. Homemade solution
17. How would you recommend cleaning of the device used
for NSI? (you can choose multiple)
a. Rinsing with running water
b. Cleaning in a microwave oven
c. Cleaning with a antimicrobial solution
d. Cleaning with boiling water
e. Cleaning with soap
f. I don’t give instructions concerning the cleaning
18. How often would you recommend cleaning of the device
used for NSI? (select one)
a. Few times a month
b. Weekly
c. Every time before or after use
d. Every time before and after use








g. None of the above
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